FUSN / Fusion Pharmaceuticals Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Fusion Pharmaceuticals Inc.
US ˙ NasdaqGS ˙ CA36118A1003
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier18.757.589 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Fusion Pharmaceuticals Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FUSN / Fusion Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-08-11 GANNON STEVEN 44.400 2,0300 44.400 2,0300 90.132 299 5.3300 146.520 162,56
2021-08-23 GANNON STEVEN 2.829 7,9850 2.829 7,9850 22.590
2021-08-19 GANNON STEVEN 3.000 8,0500 3.000 8,0500 24.150
2021-08-18 GANNON STEVEN 171 8,0500 171 8,0500 1.377
2021-08-16 GANNON STEVEN 6.000 8,1000 6.000 8,1000 48.600
2020-06-30 ORBIMED ADVISORS LLC 192.100 17,0000 192.100 17,0000 3.265.700
2020-06-30 ORBIMED ADVISORS LLC 705.900 17,0000 705.900 17,0000 12.000.300
2020-06-30 Preston Heather 8.823 17,0000 8.823 17,0000 149.991
2020-06-30 O'Leary James J 300 17,0000 300 17,0000 5.100

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FUSN / Fusion Pharmaceuticals Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FUSN / Fusion Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2020-12-24 ADAMS STREET PARTNERS LLC 1.584 12,3200 1.584 12,3200 19.515 344 4.7 -12.069 -61,85
2020-12-24 ADAMS STREET PARTNERS LLC 681 12,3200 681 12,3200 8.390
2020-12-24 ADAMS STREET PARTNERS LLC 455 12,3200 455 12,3200 5.606
2020-12-24 ADAMS STREET PARTNERS LLC 469 12,3200 469 12,3200 5.778
2020-12-24 ADAMS STREET PARTNERS LLC 611 12,3200 611 12,3200 7.528
2020-12-23 ADAMS STREET PARTNERS LLC 1.905 12,3900 1.905 12,3900 23.603
2020-12-23 ADAMS STREET PARTNERS LLC 819 12,3900 819 12,3900 10.147
2020-12-23 ADAMS STREET PARTNERS LLC 547 12,3900 547 12,3900 6.777
2020-12-23 ADAMS STREET PARTNERS LLC 564 12,3900 564 12,3900 6.988
2020-12-23 ADAMS STREET PARTNERS LLC 734 12,3900 734 12,3900 9.094

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FUSN / Fusion Pharmaceuticals Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2024-06-04 2024-06-04 4 Valliant John FUSN Common Stock D - Sale to Issuer D -318.147 0
2024-06-04 2024-06-04 4 GANNON STEVEN FUSN Common Stock D - Sale to Issuer D -56.400 0
2024-06-04 2024-06-04 4 Rawat Mohit FUSN Common Stock D - Sale to Issuer D -21.699 0
2024-06-04 2024-06-04 4 Crowley John J FUSN Common Stock D - Sale to Issuer D -10.410 0
2024-06-04 2024-06-04 4 Leamon Christopher P FUSN Common Stock D - Sale to Issuer D -11.957 0
2024-06-04 2024-06-04 4 Burak Eric FUSN Common Stock D - Sale to Issuer D -38.490 0
2024-01-05 2023-08-31 4 Leamon Christopher P FUSN Common Stock A - Award D 11.957 11.957
2024-01-05 2023-08-31 4 Rawat Mohit FUSN Common Stock A - Award D 12.843 12.843
2022-11-14 2022-11-11 4 Khuong Chau Quang FUSN Common Stock A - Award D 2,3800 42.093 100 42.093
2022-08-11 2022-08-11 4 GANNON STEVEN FUSN Common Stock P - Purchase D 2,0300 44.400 90 56.400
2022-04-27 2022-04-27 4 Valliant John FUSN Common Stock S - Sale D 6,0300 -4.511 -27 318.147
2022-04-27 2022-04-26 4 Valliant John FUSN Common Stock S - Sale D 6,0700 -2.147 -13 322.658
2022-04-27 2022-04-25 4 Valliant John FUSN Common Stock S - Sale D 6,0300 -2.036 -12 324.805
2022-04-22 2022-04-21 4 Valliant John FUSN Common Stock S - Sale D 6,0100 -922 -6 326.841
2022-04-22 2022-04-20 4 Valliant John FUSN Common Stock S - Sale D 6,0200 -367 -2 327.763
2022-04-13 2022-04-13 4 Valliant John FUSN Common Stock S - Sale D 6,4100 -11.994 -77 328.130
2022-04-13 2022-04-12 4 Valliant John FUSN Common Stock S - Sale D 7,1000 -18.255 -130 340.124
2022-04-13 2022-04-11 4 Valliant John FUSN Common Stock S - Sale D 7,3700 -2.600 -19 358.379
2022-04-08 2022-04-08 4 Valliant John FUSN Common Stock S - Sale D 7,5200 -826 -6 360.979
2022-04-08 2022-04-07 4 Valliant John FUSN Common Stock S - Sale D 7,5600 -1.255 -9 361.805
2022-04-08 2022-04-06 4 Valliant John FUSN Common Stock S - Sale D 7,5800 -100 -1 363.060
2022-04-05 2022-04-05 4 Valliant John FUSN Common Stock S - Sale D 7,6700 -2.100 -16 363.160
2022-04-05 2022-04-04 4 Valliant John FUSN Common Stock S - Sale D 7,8100 -700 -5 365.260
2022-04-05 2022-04-01 4 Valliant John FUSN Common Stock S - Sale D 7,7500 -1.000 -8 365.960
2022-04-01 2022-03-30 4 Valliant John FUSN Common Stock S - Sale D 7,5200 -300 -2 366.960
2022-03-29 2022-03-29 4 Valliant John FUSN Common Stock S - Sale D 7,5200 -200 -2 367.260
2022-03-29 2022-03-28 4 Valliant John FUSN Common Stock S - Sale D 7,5500 -9.600 -72 367.460
2022-03-29 2022-03-25 4 Valliant John FUSN Common Stock S - Sale D 7,4200 -500 -4 377.060
2022-03-24 2022-03-23 4 Valliant John FUSN Common Stock S - Sale D 7,5000 -100 -1 378.260
2022-03-24 2022-03-22 4 Valliant John FUSN Common Stock S - Sale D 7,5300 -4.000 -30 378.360
2022-03-24 2022-03-21 4 Valliant John FUSN Common Stock S - Sale D 7,4600 -700 -5 377.560
2022-03-21 2022-03-21 4 Valliant John FUSN Common Stock S - Sale D 7,4700 -1.500 -11 382.360
2022-03-21 2022-03-18 4 Valliant John FUSN Common Stock S - Sale D 7,6100 -1.204 -9 383.860
2022-03-21 2022-03-17 4 Valliant John FUSN Common Stock S - Sale D 7,5100 -900 -7 385.064
2022-03-16 2022-03-16 4 Valliant John FUSN Common Stock S - Sale D 6,9900 -100 -1 385.964
2022-03-16 2022-03-15 4 Valliant John FUSN Common Stock S - Sale D 7,1200 -100 -1 386.064
2022-03-16 2022-03-14 4 Valliant John FUSN Common Stock S - Sale D 6,9600 -1.300 -9 386.164
2022-03-14 2022-03-11 4 Valliant John FUSN Common Stock S - Sale D 7,1300 -100 -1 387.464
2022-03-14 2022-03-10 4 Valliant John FUSN Common Stock S - Sale D 7,0600 -1.900 -13 387.564
2022-03-14 2022-03-09 4 Valliant John FUSN Common Stock S - Sale D 6,9400 -822 -6 389.464
2022-03-08 2022-03-08 4 Valliant John FUSN Common Stock S - Sale D 6,9200 -3.004 -21 390.286
2022-03-08 2022-03-07 4 Valliant John FUSN Common Stock S - Sale D 6,9900 -3.100 -22 393.290
2022-03-08 2022-03-04 4 Valliant John FUSN Common Stock S - Sale D 7,3200 -8.400 -61 396.390
2022-03-03 2022-03-03 4 Valliant John FUSN Common Stock S - Sale D 7,2800 -200 -1 404.790
2022-03-03 2022-03-02 4 Valliant John FUSN Common Stock S - Sale D 7,4400 -26.546 -198 404.990
2022-03-03 2022-03-01 4 Valliant John FUSN Common Stock S - Sale D 7,3700 -847 -6 431.536
2022-02-28 2022-02-28 4 Valliant John FUSN Common Stock S - Sale D 7,4000 -3.100 -23 432.383
2022-02-28 2022-02-25 4 Valliant John FUSN Common Stock S - Sale D 7,5700 -8.152 -62 435.483
2022-02-28 2022-02-24 4 Valliant John FUSN Common Stock S - Sale D 7,4100 -2.500 -19 443.635
2022-02-23 2022-02-23 4 Valliant John FUSN Common Stock S - Sale D 7,7700 -29.299 -228 446.135
2022-02-23 2022-02-22 4 Valliant John FUSN Common Stock S - Sale D 7,8500 -4.100 -32 475.434
2022-02-23 2022-02-18 4 Valliant John FUSN Common Stock S - Sale D 7,8800 -4.898 -39 479.534
2022-02-17 2022-02-17 4 Valliant John FUSN Common Stock S - Sale D 7,9800 -1.700 -14 484.432
2022-02-17 2022-02-16 4 Valliant John FUSN Common Stock S - Sale D 7,9900 -33.202 -265 486.132
2022-02-17 2022-02-15 4 Valliant John FUSN Common Stock S - Sale D 8,3300 -12.600 -105 519.334
2022-02-03 2022-02-01 4 Valliant John FUSN Stock Option (Right to Buy) A - Award D 7,70 406.600 406.600
2022-02-03 2022-02-01 4 Rawat Mohit FUSN Stock Option (Right to Buy) A - Award D 7,70 77.900 77.900
2022-02-03 2022-02-01 4 Crowley John J FUSN Stock Option (Right to Buy) A - Award D 7,70 167.000 167.000
2022-02-03 2021-08-31 4 Crowley John J FUSN Common Stock A - Award D 3.910 10.410
2022-02-03 2022-02-01 4 O'Leary James J FUSN Stock Option (Right to Buy) A - Award D 7,70 159.000 159.000
2022-02-03 2021-08-31 4 O'Leary James J FUSN Common Stock A - Award D 1.722 2.022
2022-02-03 2022-02-01 4 Burak Eric FUSN Stock Option (Right to Buy) A - Award D 7,70 168.200 168.200
2021-11-02 2021-11-01 4 Leamon Christopher P FUSN Stock Option (Right to Buy) A - Award D 7,09 218.000 218.000
2021-09-30 2021-09-27 4 Rawat Mohit FUSN Stock Option (Right to Buy) A - Award D 8,26 257.000 257.000
2021-08-23 2021-08-23 4 GANNON STEVEN FUSN Common Stock P - Purchase D 7,9850 2.829 23 12.000
2021-08-20 2021-08-19 4 GANNON STEVEN FUSN Common Stock P - Purchase D 8,0500 3.000 24 9.171
2021-08-20 2021-08-18 4 GANNON STEVEN FUSN Common Stock P - Purchase D 8,0500 171 1 6.171
2021-08-17 2021-08-16 4 GANNON STEVEN FUSN Common Stock P - Purchase D 8,1000 6.000 49 6.000
2021-06-07 2021-06-04 4 Lee Philina FUSN Stock Option (Right to Buy) A - Award D 8,15 17.000 17.000
2021-06-07 2021-06-04 4 Preston Heather FUSN Stock Option (Right to Buy) A - Award D 8,15 17.000 17.000
2021-06-07 2021-06-04 4 GANNON STEVEN FUSN Stock Option (Right to Buy) A - Award D 8,15 17.000 17.000
2021-06-07 2021-06-04 4 Khuong Chau Quang FUSN Stock Option (Right to Buy) A - Award D 8,15 17.000 17.000
2021-06-07 2021-06-04 4 Duncan Barbara Gayle FUSN Stock Opion (Right to Buy) A - Award D 8,15 17.000 17.000
2021-06-07 2021-06-04 4 CAGNONI PABLO J FUSN Stock Option (Right to Buy) A - Award D 8,15 17.000 17.000
2021-06-07 2021-06-04 4 Bergstrom Donald A FUSN Stock Option (Right to Buy) A - Award D 8,15 17.000 17.000
2021-04-01 2021-04-01 4 Bergstrom Donald A FUSN Stock Option (Right to Buy) A - Award D 10,59 34.000 34.000
2021-02-12 2021-02-11 4 Lee Philina FUSN Stock Option (Right to Buy) A - Award D 11,75 30.000 30.000
2021-02-08 2021-02-04 4 Crowley John J FUSN Stock Option (Right to Buy) A - Award D 11,90 138.000 138.000
2021-02-08 2021-02-04 4 Valliant John FUSN Stock Option (Right to Buy) A - Award D 11,90 336.000 336.000
2021-02-08 2021-02-04 4 Burak Eric FUSN Stock Option (Right to Buy) A - Award D 11,90 136.600 136.600
2021-02-08 2021-02-04 4 Burak Eric FUSN Stock Option (Right to Buy) A - Award D 11,90 41.000 41.000
2021-02-08 2021-02-04 4 Burak Eric FUSN Stock Option (Right to Buy) A - Award D 11,90 139.000 139.000
2021-02-08 2021-02-04 4 O'Leary James J FUSN Stock Option (Right to Buy) A - Award D 11,90 114.000 114.000
2020-12-29 2020-12-24 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Stock S - Sale I 12,3200 -1.584 -20 1.457.115
2020-12-29 2020-12-24 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Stock S - Sale I 12,3200 -681 -8 626.000
2020-12-29 2020-12-24 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Stock S - Sale I 12,3200 -455 -6 418.190
2020-12-29 2020-12-24 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Stock S - Sale I 12,3200 -469 -6 431.117
2020-12-29 2020-12-24 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Stock S - Sale I 12,3200 -611 -8 561.634
2020-12-28 2020-12-23 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Stock S - Sale I 12,3900 -1.905 -24 1.458.699
2020-12-28 2020-12-23 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Stock S - Sale I 12,3900 -819 -10 626.681
2020-12-28 2020-12-23 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Stock S - Sale I 12,3900 -547 -7 418.645
2020-12-28 2020-12-23 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Stock S - Sale I 12,3900 -564 -7 431.586
2020-12-28 2020-12-23 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Stock S - Sale I 12,3900 -734 -9 562.245
2020-11-03 2020-10-30 4 Duncan Barbara Gayle FUSN Stock Option (Right to Buy) A - Award D 12,40 30.000 30.000
2020-07-02 2020-06-30 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. FUSN Warrants to purchase Common Shares C - Conversion I 89.118 89.118
2020-07-02 2020-06-30 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. FUSN Warrants to purchase Class B Preferred Shares C - Conversion I -475.802 0
2020-07-02 2020-06-30 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. FUSN Class B Preferred Shares C - Conversion I -5.059.460 0
2020-07-02 2020-06-30 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. FUSN Class A Preferred Shares C - Conversion I -10.666.667 0
2020-07-02 2020-06-30 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. FUSN Common Shares P - Purchase I 17,0000 725.000 12.325 3.670.516
2020-07-02 2020-06-30 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. FUSN Common Shares C - Conversion I 2.945.516 2.945.516
2020-07-02 2020-06-30 4 TPG Group Holdings (SBS) Advisors, Inc. See Explanation of Responses FUSN Class B Preferred Shares C - Conversion I -4.289.296 0
2020-07-02 2020-06-30 4 TPG Group Holdings (SBS) Advisors, Inc. See Explanation of Responses FUSN Class A Preferred Shares C - Conversion I -8.000.000 0
2020-07-02 2020-06-30 4 TPG Group Holdings (SBS) Advisors, Inc. See Explanation of Responses FUSN Common Stock P - Purchase I 17,0000 250.000 4.250 2.551.794
2020-07-02 2020-06-30 4 TPG Group Holdings (SBS) Advisors, Inc. See Explanation of Responses (1)(2)(4)5) FUSN Common Stock C - Conversion I 2.301.794 2.301.794
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Class B Preferred Shares C - Conversion I -2.237.832 0
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Class B Preferred Shares C - Conversion I -961.412 0
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Class B Preferred Shares C - Conversion I -642.260 0
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Class B Preferred Shares C - Conversion I -662.111 0
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Class B Preferred Shares C - Conversion I -862.558 0
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Class A Preferred Shares C - Conversion I -5.560.341 0
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Class A Preferred Shares C - Conversion I -2.388.822 0
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Class A Preferred Shares C - Conversion I -1.595.823 0
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Class A Preferred Shares C - Conversion I -1.645.147 0
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Class A Preferred Shares C - Conversion I -2.143.200 0
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Shares C - Conversion I 419.148 1.460.604
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Shares C - Conversion I 180.072 627.500
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Shares C - Conversion I 120.294 419.192
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Shares C - Conversion I 124.013 432.150
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Shares C - Conversion I 161.556 562.979
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Shares C - Conversion I 1.041.456 1.041.456
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Shares C - Conversion I 447.428 447.428
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Shares C - Conversion I 298.898 298.898
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Shares C - Conversion I 308.137 308.137
2020-07-02 2020-06-30 4 ADAMS STREET PARTNERS LLC See footnotes FUSN Common Shares C - Conversion I 401.423 401.423
2020-07-02 2020-06-30 4 ORBIMED ADVISORS LLC By OrbiMed Private Investments VII, L.P. FUSN Class B Preferred Shares C - Conversion I -11.878.051 0
2020-07-02 2020-06-30 4 ORBIMED ADVISORS LLC By OrbiMed Partners Master Fund Limited FUSN Common Shares P - Purchase I 17,0000 192.100 3.266 192.100
2020-07-02 2020-06-30 4 ORBIMED ADVISORS LLC By OrbiMed Private Investments VII, L.P. FUSN Common Shares P - Purchase I 17,0000 705.900 12.000 2.930.670
2020-07-02 2020-06-30 4 ORBIMED ADVISORS LLC By OrbiMed Private Investments VII, L.P. FUSN Common Shares C - Conversion I 2.224.770 2.224.770
2020-07-02 2020-06-30 4 VARIAN MEDICAL SYSTEMS INC FUSN Class B Preferred Shares C - Conversion D -14.517.619 0
2020-07-02 2020-06-30 4 VARIAN MEDICAL SYSTEMS INC FUSN Class A Preferred Shares C - Conversion D -2.666.667 0
2020-07-02 2020-06-30 4 VARIAN MEDICAL SYSTEMS INC FUSN Common Shares C - Conversion D 2.719.164 3.218.632
2020-07-02 2020-06-30 4 VARIAN MEDICAL SYSTEMS INC FUSN Common Shares C - Conversion D 499.468 499.468
2020-07-02 2020-06-30 4 HealthCap VII, L.P. FUSN Class B Preferred Exchangeable Shares C - Conversion I -5.712.216 0
2020-07-02 2020-06-30 4 HealthCap VII, L.P. FUSN Class A Preferred Exchangeable Shares C - Conversion I -13.333.333 0
2020-07-02 2020-06-30 4 HealthCap VII, L.P. FUSN Common Shares P - Purchase I 17,0000 240.000 4.080 3.807.247
2020-07-02 2020-06-30 4 HealthCap VII, L.P. FUSN Common Shares C - Conversion I 1.069.902 3.567.247
2020-07-02 2020-06-30 4 HealthCap VII, L.P. FUSN Common Shares C - Conversion I 2.497.345 2.497.345
2020-07-02 2020-06-30 4 Christenson Johan FUSN Class B Preferred Exchangeable Shares C - Conversion I -5.712.216 0
2020-07-02 2020-06-30 4 Christenson Johan FUSN Class A Preferred Exchangeable Shares C - Conversion I -13.333.333 0
2020-07-02 2020-06-30 4 Christenson Johan FUSN Common Shares P - Purchase I 17,0000 240.000 4.080 3.807.247
2020-07-02 2020-06-30 4 Christenson Johan FUSN Common Shares C - Conversion I 1.069.902 3.567.247
2020-07-02 2020-06-30 4 Christenson Johan FUSN Common Shares C - Conversion I 2.497.345 2.497.345
2020-07-02 2020-06-30 4 Khuong Chau Quang FUSN Class B Preferred Shares C - Conversion I -11.878.051 0
2020-07-02 2020-06-30 4 Khuong Chau Quang FUSN Common Shares P - Purchase I 17,0000 192.100 3.266 192.100
2020-07-02 2020-06-30 4 Khuong Chau Quang FUSN Common Shares P - Purchase I 17,0000 705.900 12.000 2.930.670
2020-07-02 2020-06-30 4 Khuong Chau Quang FUSN Common Shares C - Conversion I 2.224.770 2.224.770
2020-07-02 2020-06-30 4 Crowley John J FUSN Common Stock P - Purchase D 17,0000 6.500 110 6.500
2020-07-02 2020-06-30 4 Preston Heather FUSN Common Stock P - Purchase D 17,0000 8.823 150 8.823
2020-07-02 2020-06-30 4 O'Leary James J FUSN Common Stock P - Purchase D 17,0000 300 5 300
2020-06-30 2020-06-25 4 Khuong Chau Quang FUSN Stock Option (Right to Buy) A - Award D 17,00 30.000 30.000
2020-06-30 2020-06-02 4 Khuong Chau Quang FUSN Class B Preferred Shares P - Purchase I 1,1514 5.939.025 6.838 11.878.051
2020-06-30 2020-01-10 4 Khuong Chau Quang FUSN Warrants to Purchase Class B Preferred Shares A - Award I 1,15 359.377 359.377
2020-06-30 2020-06-25 4 Burak Eric FUSN Stock Option (Right to Buy) A - Award D 17,00 69.980 69.980
2020-06-30 2020-06-25 4 Burak Eric FUSN Stock Option (Right to Buy) A - Award D 17,00 44.754 44.754
2020-06-30 2020-02-06 4 Burak Eric FUSN Stock Option (Right to Buy) A - Award D 2,99 38.561 38.561
2020-06-30 2020-06-25 4 Preston Heather FUSN Stock Option (Right to Buy) A - Award D 17,00 30.000 30.000
2020-06-30 2020-06-25 4 CAGNONI PABLO J FUSN Stock Option (Right to Buy) A - Award D 17,00 30.000 30.000
2020-06-30 2020-06-25 4 Christenson Johan FUSN Stock Option (Right to Buy) A - Award D 17,00 30.000 30.000
2020-06-30 2020-06-02 4 Christenson Johan FUSN Class B Preferred Exchangeable Shares P - Purchase I 1,1514 2.856.108 3.289 5.712.216
2020-06-30 2020-01-10 4 Christenson Johan FUSN Warrants to purchase Class B Preferred Exchangeable Shares A - Award I 1,15 576.233 576.233
2020-06-30 2020-06-25 4 Valliant John FUSN Stock Option (Right to Buy) A - Award D 17,00 372.948 372.948
2020-06-30 2020-06-25 4 Valliant John FUSN Stock Option (Right to Buy) A - Award D 17,00 206.541 206.541
2020-06-30 2020-02-06 4 Valliant John FUSN Stock Option (Right to Buy) A - Award D 2,99 173.528 173.528
2020-06-30 2020-06-25 4 Lamb Damian FUSN Stock Option (Right to Buy) A - Award D 17,00 30.000 30.000
2020-06-30 2020-06-25 4 Crowley John J FUSN Stock Option (Right to Buy) A - Award D 17,00 60.852 60.852
2020-06-30 2020-06-25 4 Crowley John J FUSN Stock Option (Right to Buy) A - Award D 17,00 26.972 26.972
2020-06-30 2020-02-06 4 Crowley John J FUSN Stock Option (Right to Buy) A - Award D 2,99 38.561 38.561
2020-06-30 2020-06-25 4 O'Leary James J FUSN Stock Option (Right to Buy) A - Award D 17,00 60.852 60.852
2020-06-30 2020-06-25 4 O'Leary James J FUSN Stock Option (Right to Buy) A - Award D 17,00 26.971 26.971
2020-06-30 2020-03-16 4 O'Leary James J FUSN Stock Option (Right to Buy) A - Award D 4,44 351.921 351.921
2020-06-30 2020-06-25 4 GANNON STEVEN FUSN Stock Option (Right to Buy) A - Award D 17,00 30.000 30.000
2020-06-30 2020-01-19 4 GANNON STEVEN FUSN Stock Option (Right to Buy) A - Award D 2,35 141.011 141.011
2020-06-25 3 Burak Eric FUSN Non-Voting Common Shares I 76.980
2020-06-25 3 Burak Eric FUSN Non-Voting Common Shares I 76.980
2020-06-25 3 Burak Eric FUSN Non-Voting Common Shares I 76.980
2020-06-25 3 Valliant John FUSN Common Shares I 1.063.868
2020-06-25 3 Valliant John FUSN Common Shares I 1.063.868
2020-06-25 3 Valliant John FUSN Common Shares I 1.063.868
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista